Pre-clinical and clinical evaluation of the HYPERSCINT plastic scintillation dosimetry research platform for in vivo dosimetry during radiotherapy

The purpose of this work is to evaluate the Hyperscint-RP100 scintillation dosimetry research platform (Hyperscint-RP100, Medscint Inc., Quebec, QC, Canada) designed for clinical quality assurance (QA) for use in in vivo dosimetry measurements.

J Appl Clin Med Phys. 2022
I.Schoepper (1), S.Dieterich (2), E.Alonzo Trestrail (3), M.Sean Kent (1) | Department of Radiation Oncology, University of California Davis School of Veterinary Medicine, Davis, California, USA, Department of Radiation Oncology, University of California Davis, Medical Center, Sacramento, California, USA, Pacific Crest Medical Physics, Chico, California, USA

Pre-Clinical and Clinical Evaluation of the HYPERSCINT Scintillation Dosimetry Research Platform

The purpose of this work is to evaluate the HYPERSCINT scintillation dosimetry research platform (Medscint Inc., Quebec City, Canada) designed for clinical QA for use in in-vivo dosimetry measurements.

2020 AAPM AM
I.Schoepper, E.Trestrail, S.Dieterich, M.Kent | WR Pritchard Veterinary Medical Teaching Hospital, UC Davis School of Veterinary Medicine UC Davis School Of Veterinary Medicine, Pacific Crest Medical Physics ,Chico, CA, UC Davis Medical Center, Sacramento, CA, Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine, Davis, CA